References
Isserman SM, Leppo JA, Udelson JE. Detection of coronary artery disease. In: Ell PJ, Gambhir SS, editors. Nuclear medicine in clinical diagnosis and treatment. Philadelphia: Churchill Livingstone; 2004. p. 1109–30.
Cardiolite [package insert]. North Billerica (MA): Bristol-Myers Squibb Medical Imaging; 2003.
Hines H, Kayayan R, Colsher J, Hashimoto D, Schubert R, Fernando J, et al. Recommendations for implementing SPECT instrumentation quality control. Nuclear Medicine Section—National Electrical Manufacturers Association (NEMA). Eur J Nucl Med 1999;26:527–32.
Berg GEB, Michanek AMK, Holmberg ECV, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 1996;37:228–32.
Pollard KR, Lewellen TK, Kaplan MS, Haynor DR, Miyaoka RS, Eary JF, et al. Energy-based scatter corrections for scintillation camera images of iodine-131. J Nucl Med 1996;37:2030–7.
Pollard KR, Bice AN, Durack LD, Eary JF, Lewellen TK. Camerainduced Compton scatter and collimator penetration in iodine-131 imaging [abstract]. J Nucl Med 1992;5:889.
Flemming JS, Alaamer AS. Influence of collimator characteristics on quantification in SPECT. J Nucl Med 1996;37:1832–6.
Vaccaro RM, Sorek M, Wulkan IA, Pugliese P. Therapeutic radioiodine interference with subsequent diagnostic imaging. Clin Nucl Med 1994;19:829.
Orzel JA, Kruyer WB, Borchert RD. Radioiodine therapy precludes thallium-201 myocardial scintigraphy. Clin Nucl Med 1987;12:110–2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robertson, A.F., Bailey, D.L., Roach, P.J. et al. Tc-99m sestamibi myocardial perfusion imaging after undisclosed I-131 therapy. J Nucl Cardiol 13, 722–724 (2006). https://doi.org/10.1016/j.nuclcard.2006.06.116
Issue Date:
DOI: https://doi.org/10.1016/j.nuclcard.2006.06.116